二氢杨梅素联合依托泊苷对绒毛膜癌细胞JAR的抑制作用

王康 许倩 左彦珍 刘镭 鲁艳杰 雷赟涛 崔莹 李玉红*

doi:10.16098/j.issn.0529-1356.2018.03.010

PDF(696 KB)

解剖学报 ›› 2018, Vol. 49 ›› Issue (3) : 330-336. DOI: 10.16098/j.issn.0529-1356.2018.03.010

肿瘤生物学

二氢杨梅素联合依托泊苷对绒毛膜癌细胞JAR的抑制作用

王康¹ 许倩²左彦珍³ 刘镭⁴ 鲁艳杰¹ 雷赟涛¹崔莹¹ 李玉红^5*

作者信息 +

Inhibitory effect of dihydromyricetin combined with etoposide on the choriocarcinoma cell JAR

WANG Kang¹ XU Qian² ZUO Yan-zhen³ LIU Lei⁴ LU Yan-jie¹ LEI Yun-tao¹ CUI Ying1 LI Yu-hong^5*

Author information +

文章历史 +

摘要

目的探讨二氢杨梅素（DMY）联合依托泊苷（VP16）对绒毛膜癌细胞JAR的抑制作用及其相关机制。方法体外培养JAR细胞，设空白对照组、DMY组、VP16组以及DMY与VP16联合（DMY+VP16）组。MTT法检测各组细胞增殖情况；Annexin V-FITC/PI双染流式细胞术分析各组细胞的凋亡率；克隆形成实验检测细胞生存能力；Western blotting法检测凋亡抑制蛋白Bcl-2、细胞凋亡抑制蛋白2（c-IAP2）表达水平。结果 MTT检测结果显示，与空白对照组比较，DMY组、VP16组及DMY+VP16组在24 h和48 h时间点的细胞存活率均下降，且DMY+VP16组细胞存活率下降最为明显；Annexin V-FITC/PI双染流式细胞术结果显示，与对照组相比各实验组凋亡率均有增高，DMY+VP16组凋亡率明显高于各单独用药组；克隆形成实验结果显示，对于JAR细胞，实验组的克隆球数目均少于对照组，且DMY+VP16组克隆球数目最少；对于正常肝脏HL7702细胞,DMY组与对照组相比无明显差异，VP16组与DMY+VP16相比亦无明显差异；Western blotting实验结果显示，与对照组相比，无论DMY和VP16单独还是联合使用均可下调Bcl-2、c-IAP2蛋白表达，同时DMY+VP16组下调作用最明显。结论二氢杨梅素联合依托泊苷明显增强对绒毛膜癌细胞JAR的生长抑制作用，联合使用可以减少化疗药物VP16的用量，其抑制肿瘤细胞作用可能与下调Bcl-2、c-IAP2蛋白的表达有关。

Abstract

Objective To investigate the inhibitory effect and related mechanism of dihydromyricetin(DMY) combined with etoposide(VP16) on the choriocarcinoma cell JAR.Methods JAR cells cultured in vitro were devided into control group, DMY group, VP16 group and DMY+VP16 group. The cell proliferation was measured by MTT assay. The apoptosis rate of each group was analyzed by annexin V-FITC/PI double dye flow cytometry. The cell viability was measured by the colony formation capability assay. The protein expression levels of Bcl-2, inhibitor apoptosis protein 2(c-IAP2) were detected by Western blotting analysis. Results The result of MTT assay showed that compared with the control group, the cell survival ratio of DMY group, VP16 group and DMY+VP16 group reduced at 24 hours and 48 hours.The result of double dye flow cytometry showed that the apoptosis rate of the experimental groups were higher than that of the control group, and the apoptosis rate of DMY+VP16 group was significantly higher than those treated with DMY or VP16 alone.The result of the colony formation capability assay showed that,for JAR cells,the number of clones in experimental groups were less than that in the control group, and the number of clones in DMY+ VP16 group was the least. For normal liver HL7702 cells, there was no significant difference between DMY group and the control group, and there was no significant difference between VP16 group and DMY+VP16.The result of Western blotting showed that the protein expression levels of Bcl-2 and c-IAP2 in experimental group decreased compared with those in the control group, and the decrease of he protein expression levels of Bcl-2 and c-IAP2 in DMY+VP16 group were the most significant. Conclusion Dihydromyricetin combined with etoposide enhanced the inhibitory effect on choriocarcinoma cell JAR, which can reduce the dosage of the chemotherapy drug VP16.The inhibitory effect of tumor cells may be related to the down-regulation of protein expression of Bcl-2, C-IAP2.

导出引用

王康许倩左彦珍刘镭鲁艳杰雷赟涛崔莹李玉红. 二氢杨梅素联合依托泊苷对绒毛膜癌细胞JAR的抑制作用[J]. 解剖学报. 2018, 49(3): 330-336 https://doi.org/10.16098/j.issn.0529-1356.2018.03.010

WANG Kang XU Qian ZUO Yan-zhen LIU Lei LU Yan-jie LEI Yun-tao CUI Ying LI Yu-hong. Inhibitory effect of dihydromyricetin combined with etoposide on the choriocarcinoma cell JAR[J]. Acta Anatomica Sinica. 2018, 49(3): 330-336 https://doi.org/10.16098/j.issn.0529-1356.2018.03.010

参考文献

［1］Pang JL,Chen J,LI YY,et al.Effect of curcumin on invasion and adhesion of human choriocarcinoma JAR cell strains［J］.Maternal and Child Health Care of China,2012,27(3): 423-425.（in Chinese）

庞江琳,陈杰,李英勇,等.姜黄素对人类绒癌JAR细胞株侵袭粘附的影响［J］.中国妇幼保健,2012,27(3): 423-425.

［2］Zhang KY,Zuo XL,Li YH,et al.Effects of transforming growth factor-β1 on the invasiveness of the JEG-3,the protein expression of uPA,uPAR and PAI-1［J］.Maternal and Child Health Care of China, 2014,29(5):777-780.（in Chinese）

张孔雁,左欣鹭,李玉红,等.TGF-β1对绒毛膜癌JEG-3细胞侵袭能力及其uPA、uPAR、PAI-1蛋白表带的影响［J］.中国妇幼保健, 2014,29(5):777-780.

［3］Bromberg KD, Burgin AB, Osheroff N. A two-drug model for etoposide action against human topoisomerase Ⅱ alpha［J］. Journal Biol Chem, 2003, 278(9):7406-7412.

［4］Wang RB, Liu X. Development of DNA topoisomerase Ⅱ inhibitors［J］. Strait Pharmaceutical Journal, 2009, 22(4):1-5.（in Chinese）

王汝冰, 刘潇. DNA拓扑异构酶Ⅱ抑制剂研究进展［J］. 海峡药学, 2009, 22(4):1-5.

［5］Schutte NS,Malouff JM.A meta-analytic review of the effects of mindfulness meditation on telomerase activity ［J］. Psychoneuroendocrinology,2014, 42(1): 45-48.

［6］Gomez DE,Armando RG,Farina HG,et al.Telomere structure and telomerase in health and disease(review)［J］. Int J Oncol,2012, 41(5): 1561-1569.

［7］Ji FJ, Tian XF, Liu XW, et al. Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells［J］. Genet Mol Res, 2015, 14(4):15564-15571.

［8］Liu B, Tan X, Liang J, et al. A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells［J］. Sci Rep, 2014, 4:7041.

［9］Wang Z, Sun X, Feng Y, et al. Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells［J］. Anticancer Drugs, 2017, 28(3):281-288.

［10］Zhou DZ, Sun HY, Yue JQ, et al. Dihydromyricetin induces apoptosis and cytoprotective autophagy through ROS-NF-κB signalling in human melanoma cells［J］. Free Radic Res, 2017, 51(5):517-528.

［11］Xu Y, Wang S, Chan HF, et al. Dihydromyricetin induces apoptosis and reverses drug resistance in ovarian cancer cells by p53-mediated downregulation of survivin［J］. Sci Rep, 2017, 7:46060.

［12］Guo QQ, Yuan J, Zeng JH, et al. Synthesis of dihydromyricetin-manganese (ii) complex and interaction with DNA ［J］. J Mol Struct, 2012, 1027(43): 64-69.

［13］Hou XL, Wang WQ, Shi ChY, et al. Research progress in pharmacological effects of dihydromyricelin［J］. Chinese Traditional and Herbal Drugs, 2015, 46(4):603-609.（in Chinese）

侯小龙, 王文清, 施春阳,等. 二氢杨梅素药理作用研究进展［J］. 中草药, 2015, 46(4):603-609.

［14］Shan ChM，Liu TSh，Ma Y, et al.Study on the expressions of genes bcl-2,bax and apoptosis in human cholangicellular carcinomas［J］.Acta Anatomica Sinica,2002, 33(4):405-409.（in Chinese）

单长民, 刘同慎, 马云，等肝胆管癌中bcl-2、bax基因表达和细胞凋亡的研究［J］. 解剖学报, 2002, 33(4):405-409.

［15］Wu S, Liu B, Zhang Q, et al. Dihydromyricetin reduced bcl-2 expression via p53 in human hepatoma hepg2 cells［J］. PLoS One, 2013, 8(11): e76886.

［16］Lu CJ,He YF, Yuan WZ, et al.Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells［J］.World J Gastroenterol,2017, 23(34): 6242-6251.

［17］Zhang Q,Liu DY. Ampelopsin induces apoptosis via altering expression of Bcl-2/Bax and activating Caspase-3 in human hepatoma cell line Bel-7402［J］. Chinese Pharmacological Bulletin, 2009, 25(11): 1502-1506.（in Chinese）

张琼, 刘德育. 蛇葡萄素改变Bcl-2/Bax 表达和激活Caspase-3 诱导人肝癌细胞Bel-7402 凋亡［J］. 中国药理学通报, 2009, 25(11): 1502-1506.

［18］V?lp K, Brezniceanu M L, B?sser S, et al. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas［J］. Gut, 2006, 55(2):234-242.

［19］Yong-Xian G, Xiao-Huan L, Fan Z, et al. Gemcitabine inhibits proliferation and induces apoptosis in human pancreatic cancer PANC-1 cells［J］. J Cancer Res Ther, 2016, 12(Suppl):1-4.